DK1623019T3 - Begrænset glucosetilførsel til dyrecellekultur - Google Patents

Begrænset glucosetilførsel til dyrecellekultur

Info

Publication number
DK1623019T3
DK1623019T3 DK04752591.0T DK04752591T DK1623019T3 DK 1623019 T3 DK1623019 T3 DK 1623019T3 DK 04752591 T DK04752591 T DK 04752591T DK 1623019 T3 DK1623019 T3 DK 1623019T3
Authority
DK
Denmark
Prior art keywords
glucose
cell culture
feeding
restricted
rate
Prior art date
Application number
DK04752591.0T
Other languages
English (en)
Other versions
DK1623019T4 (da
Inventor
Denis Drapeau
Terry Cardoza Stanek
Yen-Tung Luan
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33476770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1623019(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of DK1623019T3 publication Critical patent/DK1623019T3/da
Publication of DK1623019T4 publication Critical patent/DK1623019T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04752591.0T 2003-05-15 2004-05-17 Begrænset glucosetilførsel til dyrecellekultur DK1623019T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47093703P 2003-05-15 2003-05-15
PCT/US2004/015597 WO2004104186A1 (en) 2003-05-15 2004-05-17 Restricted glucose feed for animal cell culture

Publications (2)

Publication Number Publication Date
DK1623019T3 true DK1623019T3 (da) 2010-09-27
DK1623019T4 DK1623019T4 (da) 2017-03-27

Family

ID=33476770

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04752591.0T DK1623019T4 (da) 2003-05-15 2004-05-17 Begrænset glucosetilførsel til dyrecellekultur

Country Status (10)

Country Link
US (1) US7429491B2 (da)
EP (1) EP1623019B2 (da)
AT (1) ATE472597T2 (da)
DE (1) DE602004027905D1 (da)
DK (1) DK1623019T4 (da)
ES (1) ES2344789T5 (da)
PL (1) PL1623019T5 (da)
PT (1) PT1623019E (da)
SI (1) SI1623019T1 (da)
WO (1) WO2004104186A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
WO2008036600A2 (en) * 2006-09-18 2008-03-27 Genentech, Inc. Methods of protein production
SI2078071T1 (sl) * 2006-11-08 2015-05-29 Wyeth Llc Racionalno zasnovana gojišča za celično kulturo
ES2657055T3 (es) 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
US8039231B2 (en) * 2008-04-17 2011-10-18 Wyeth Llc Methods for enhanced production of bone morphogenetic proteins
WO2010016943A2 (en) * 2008-08-08 2010-02-11 Biogen Idec Ma Inc. Nutrient monitoring and feedback control for increased bioproduct production
BRPI0920572A8 (pt) 2008-10-20 2015-10-27 Abbott Lab Inativação viral durante a purificação dos anticorpos
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
SI2493922T1 (sl) * 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN105189735B (zh) 2011-04-29 2019-04-12 拜康研究有限公司 在培养期间减少乳酸累积的方法和生产多肽的方法
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
HK1207960A1 (en) 2013-03-12 2016-02-19 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
DK2972238T3 (da) 2013-03-15 2023-06-19 Biogen Ma Inc Anvendelse af raman-spektroskopi til monitorering af dyrkningsmedium
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
KR102243980B1 (ko) 2013-10-11 2021-04-26 리제너론 파마슈티칼스 인코포레이티드 대사적으로 최적화된 세포 배양
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US10544395B2 (en) 2014-03-19 2020-01-28 Pfizer Inc. Method of cell culture
EP3164481A4 (en) 2014-07-02 2018-03-21 Biogen MA Inc. Cross-scale modeling of bioreactor cultures using raman spectroscopy
EP3303561A2 (en) * 2015-05-29 2018-04-11 Biogen MA Inc. Cell culture methods and systems
KR20240055117A (ko) 2015-05-29 2024-04-26 베링거 인겔하임 인터내셔날 게엠베하 연속식 배양에서의 세포-제어된 관류
TWI870789B (zh) 2015-08-04 2025-01-21 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
JP7001585B2 (ja) 2015-09-23 2022-02-04 ファイザー・インク 細胞および細胞培養の方法
CA3056011A1 (en) 2017-03-14 2018-09-20 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
US12325737B2 (en) 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
EA202191352A1 (ru) 2018-11-13 2021-08-11 Янссен Байотек, Инк. Контроль содержания микроэлементов-металлов во время продукции антител к cd38
EP3891292A1 (en) 2018-12-06 2021-10-13 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
AU2020368466A1 (en) * 2019-10-18 2022-05-12 Janssen Biotech, Inc. Dynamic monosaccharide control processes
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
WO2022047108A1 (en) 2020-08-31 2022-03-03 Regeneron Pharmaceuticals, Inc. Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants
JP7822149B2 (ja) 2020-10-02 2026-03-02 ファイザー・インク Ｒｓｖ ｆタンパク質生産のための細胞培養工程
MX2023008527A (es) 2021-01-20 2023-07-28 Regeneron Pharma Metodos para mejorar el valor proteico en cultivo celular.
WO2023059803A1 (en) 2021-10-07 2023-04-13 Regeneron Pharmaceuticals, Inc. Ph meter calibration and correction
CA3230984A1 (en) 2021-10-07 2023-04-13 Ross BROWNE Systems and methods of ph modeling and control
CN119301236A (zh) 2022-03-02 2025-01-10 瑞泽恩制药公司 用于抗体生产的生物反应器
US20240010709A1 (en) 2022-05-25 2024-01-11 Genentech, Inc. Methods for preparing mammalian cells for perfusion cell culture
WO2024218706A1 (en) 2023-04-21 2024-10-24 Pfizer Inc. Improved cells and cell cultures
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631142A (en) * 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5346826A (en) * 1989-10-18 1994-09-13 Andrews Franklin T Process for conducting biochemical reactions
US5506117A (en) * 1989-10-18 1996-04-09 Cytokinetics, Inc. Biochemical process for growing living cells by measuring the amount of nutrient added to the reaction medium
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
US5856179A (en) * 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
WO1998041611A1 (en) * 1997-03-20 1998-09-24 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6531464B1 (en) * 1999-12-07 2003-03-11 Inotek Pharmaceutical Corporation Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
AU2002316230A1 (en) 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
DE10255508A1 (de) * 2002-11-27 2004-06-17 Forschungszentrum Jülich GmbH Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen

Also Published As

Publication number Publication date
ES2344789T3 (es) 2010-09-07
DE602004027905D1 (de) 2010-08-12
PL1623019T5 (pl) 2018-02-28
EP1623019A1 (en) 2006-02-08
US20050070013A1 (en) 2005-03-31
DK1623019T4 (da) 2017-03-27
US7429491B2 (en) 2008-09-30
ATE472597T2 (de) 2010-07-15
WO2004104186A1 (en) 2004-12-02
EP1623019B1 (en) 2010-06-30
PL1623019T3 (pl) 2010-10-29
SI1623019T1 (sl) 2010-10-29
PT1623019E (pt) 2010-07-20
EP1623019B2 (en) 2017-01-25
ES2344789T5 (es) 2017-06-14

Similar Documents

Publication Publication Date Title
DK1623019T3 (da) Begrænset glucosetilførsel til dyrecellekultur
CY1110267T1 (el) Μεθοδος για την καλλιεργεια κυτταρων για την παραγωγη ουσιων
WO2008136398A1 (ja) 高濃度アミノ酸含有培地を用いた細胞の培養方法
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
DE60336548D1 (de) Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins
TW200500462A (en) Method for producing target substance by fermentation
Flamholz et al. Cell biology of photosynthesis over geologic time
HRP20070474T3 (en) Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
CN102268402B (zh) 无血清培养基及cho细胞中高效表达促红素的培养方法
WO2017049240A8 (en) Selection of pluripotent cells for production of fertile xy female mice
ATE336567T1 (de) Zellkulturmedium
Koebmann et al. The extent to which ATP demand controls the glycolytic flux depends strongly on the organism and conditions for growth
Li et al. High cell density culture of baker's yeast FX‐2 based on pH‐stat coupling with respiratory quotient
Zhang et al. Efficient production of ε-poly-l-lysine using cassava starch and fish meal by Streptomyces albulus FQC-24
Jee et al. Influence of redox potential on methanation of methanol by Methanosarcina barkeri in Eh-stat batch cultures
DE60123397D1 (de) Methode zur erhöhung der fermentationsgeschwindigkeit von hefe
Liu Effects of proteases on L-glutamic acid fermentation
Liu A growth yield model for substrate-sufficient continuous culture of microorganisms
Brewster et al. Whither life? Conjectures on the future evolution of biochemistry
WO2006031840A3 (en) Increasing the stability of recombinant adult human apohemoglobin
DK1246909T3 (da) Fremgangsmåde til fremstilling af hydroxynitril-lyaser
Hackbarth et al. Monitoring and quantification of bioelectrochemical biofilms by means of OCT in novel and customized reactor-setups
Luo et al. Regeneration of Astragalus adsurgens via somatic embryogenesis from cell suspension protoplasts.
Ross Social Progress: Real Goal Behind GDP Target
UA116537U (uk) Спосіб підвищення антигенпродукуючої біологічної активності перещеплюваних культур клітин flk-71 та flk-sbbl за допомогою наночасток срібла (аргентуму)